BSE filing, NSE: CHPLIND. Summary written from the filing by ALFA Finder's alert engine.
Callista Industries Ltd: key numbers
- Share price
- ₹131.45
- Market cap
- ₹136.7 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.00 Cr
- P/E (TTM)
- -776.8×Sector 45.0×
- Promoter holding
- 11.27%-10.23% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Callista Industries Ltd
All →Callista Industries Convertible Warrants
Callista Industries allotted 8,30,000 shares on conversion of preferential warrants, receiving a Rs 62.25 lakh balance. Allottees include non-promoter Koriander Consultants LLP and promoter Ravi Jabbar Sharma.
- Value
- ₹0.62 Cr
Callista Industries Convertible Warrants
Callista Industries allotted 4,50,000 equity shares to Koriander Consultants LLP on conversion of warrants. The balance consideration of ₹33.75 lakh was received, lifting paid-up capital to ₹10.85 crore.
- Value
- ₹0.34 Cr
Callista Industries Convertible Warrants
Ravi Jabbar Sharma, part of the promoter group, acquired equity shares and warrants upon warrant conversion at Callista Industries Ltd. The transaction is valued at ₹0.3 Crore.
- Value
- ₹0.30 Cr
Callista Industries Convertible Warrants
Callista Industries Limited allotted 4,00,000 equity shares following the conversion of convertible warrants. This capital infusion of Rs 0.4 Crore strengthens the company's equity base.
- Value
- ₹0.40 Cr
Callista Industries Other Announcement
Callista Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31 of SEBI Listing Regulations.
Callista Industries Capital Structure Change
Callista Industries allotted 4,53,412 equity shares to Koriander Consultants LLP upon conversion of convertible warrants. The company received Rs.34.00 lakh (0.34 Crore) as the balance conversion consideration.
- Value
- ₹0.34 Cr
Other capital structure change announcements
All →Jyothy Labs Capital Structure Change
Jyothy Labs' board approved a Rs 147 Crore share buyback via tender offer at Rs 215 per share. The record date is November 11, 2026.
- Value
- ₹147.0 Cr
Evonile Pharma Capital Structure Change
Evonile Pharma's Rights Issue Committee fixed November 11, 2026 as record date for a partly paid rights issue of 1,02,87,832 shares at Rs.860 each. Issue size is Rs.8,847.54 Million, with issue opening November 19, 2026.
- Value
- ₹884.8 Cr
- Execution
- Issue opening 19 Nov 2026 to closing 3 Dec 2026; listing on or about 9 Dec 2026
Share India Securities Capital Structure Change
Share India Securities allotted 44,02,000 equity shares under its Silverleaf Capital amalgamation scheme. It also granted 3,80,500 employee stock options under ESOS-II.
Arvaya Healthcare Capital Structure Change
Arvaya Healthcare's board approved the draft letter of offer for a rights issue of partly paid-up equity shares up to ₹210 Crore, plus a postal ballot. The board outcome's main decision is the rights issue, so it is classified as a capital raise step.
- Value
- ₹210.0 Cr
Mittal Life Style Capital Structure Change
Mittal Life Style set 15 December 2026 as the record date for a 10:1 consolidation of its equity shares. No cash is paid.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ approved final terms of its Rs 40 crore rights issue at Rs 25 per share. Issue runs 19 November to 3 December 2026.
- Value
- ₹40.00 Cr